The purpose of this study is to determine whether specialty care is superior to usual care in the treatment of patients at clinical high risk for psychosis.
This study is a randomized clinical effectiveness trial for patients at clinical high risk for psychosis that compares two treatments: 1) specialty care delivered in a specialized clinical for patients at clinical high risk for psychosis versus 2) treatment as usual in the community.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
16
Specialist medication, cognitive behavior therapy, family-focused therapy
Medication and psychotherapy as available form community providers
Prevention through Risk Identification Management and Education (PRIME) Clinic
New Haven, Connecticut, United States
Global Assessment of Functioning
Time frame: 24 months
Service utilization
hospitalizations and emergency room use
Time frame: 24 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.